These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 22653988)

  • 21. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
    Chung J; Brass EP; Ulrich RG; Hiatt WR
    Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
    Chen GP; Yao L; Lu X; Li L; Hu SJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
    Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells.
    Ledezma E; Wittig O; Alonso J; Cardier JE
    Melanoma Res; 2009 Apr; 19(2):69-74. PubMed ID: 19276863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.
    Bösel J; Gandor F; Harms C; Synowitz M; Harms U; Djoufack PC; Megow D; Dirnagl U; Hörtnagl H; Fink KB; Endres M
    J Neurochem; 2005 Mar; 92(6):1386-98. PubMed ID: 15748157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.
    Mabuchi H; Nohara A; Kobayashi J; Kawashiri MA; Katsuda S; Inazu A; Koizumi J;
    Atherosclerosis; 2007 Dec; 195(2):e182-9. PubMed ID: 17681347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endurance exercise increases the protein levels of PGC-1α and respiratory chain complexes in mouse skeletal muscle during atorvastatin administration.
    Nonaka K; Ozaki Y; Ito K; Sakita M; Une S; Akiyama J
    J Physiol Sci; 2019 Mar; 69(2):327-333. PubMed ID: 30536041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.
    Bouitbir J; Charles AL; Echaniz-Laguna A; Kindo M; Daussin F; Auwerx J; Piquard F; Geny B; Zoll J
    Eur Heart J; 2012 Jun; 33(11):1397-407. PubMed ID: 21775390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.
    Park WK; Kennedy RM; Larsen SD; Miller S; Roth BD; Song Y; Steinbaugh BA; Sun K; Tait BD; Kowala MC; Trivedi BK; Auerbach B; Askew V; Dillon L; Hanselman JC; Lin Z; Lu GH; Robertson A; Sekerke C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1151-6. PubMed ID: 18155906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
    Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
    Bełtowski J; Atanassova P; Chaldakov GN; Jamroz-Wiśniewska A; Kula W; Rusek M
    Atherosclerosis; 2011 Dec; 219(2):526-31. PubMed ID: 21889144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.
    Nakahara K; Kuriyama M; Sonoda Y; Yoshidome H; Nakagawa H; Fujiyama J; Higuchi I; Osame M
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):99-106. PubMed ID: 9772205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
    Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
    Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
    Mausner-Fainberg K; Luboshits G; Mor A; Maysel-Auslender S; Rubinstein A; Keren G; George J
    Atherosclerosis; 2008 Apr; 197(2):829-39. PubMed ID: 17826781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
    Vecchione C; Brandes RP
    Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.